CRISPR nanodroplet technology offers a new strategy for rapid, multiplexed, species-level identification of mycobacteria
Peer-Reviewed Publication
Updates every hour. Last Updated: 28-Oct-2026 04:16 ET (28-Oct-2026 08:16 GMT/UTC)
A commentary published in LabMed Discovery discusses a CRISPR-assisted nanodroplet platform for rapid, species-level and multiplexed identification of mycobacteria, highlighting how molecular recognition, signal encoding and spatial organization may provide a broader framework for multiplex molecular diagnostics.